HCA
PGEN icon

Horan Capital Advisors’s Precigen PGEN Stock Holding History

Horan Capital Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,000
Closed -$7K – 225
2020
Q3 		$7K Buy
+2,000
New +$9.49K ﹤0.01% 267
2020
Q1 		– Sell
-2,000
Closed -$11K – 205
2019
Q4 		$11K Hold
2,000
– – 0.01% 224
2019
Q3 		$11K Buy
+2,000
New +$13.6K 0.01% 227
2019
Q2 		– Sell
-2,000
Closed -$11K – 197
2019
Q1 		$11K Buy
+2,000
New +$13.9K 0.01% 221
2017
Q4 		– Sell
-3,650
Closed -$69K – 209
2017
Q3 		$69K Buy
+3,650
New +$75.1K 0.04% 125

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Horan Capital Advisors's PGEN Position: Q4 2020 in Review

Horan Capital Advisors sold out of Precigen (PGEN) in Q4 2020, closing a stake of 2,000 shares — an estimated $7K sold.

Horan Capital Advisors first reported a position in PGEN in Q3 2017 and held it in 5 quarters. The position peaked at $69K in Q3 2017. 151 funds tracked by Wall St. Rank hold PGEN as of Q4 2020.

  • Horan Capital Advisors reported no remaining Precigen position as of Q4 2020 after selling out during the quarter.
  • Horan Capital Advisors sold 2,000 Precigen shares in Q4 2020, an estimated $7K.
  • Horan Capital Advisors first reported a position in Precigen in Q3 2017 and held it in 5 quarters.
  • Horan Capital Advisors's Precigen position peaked at $69K in Q3 2017.
  • 151 funds tracked by Wall St. Rank held Precigen as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.